In the context of potentially novel and more effective ALS therapies, comprehensive investigations of ghrelin and GHS modulation of apoptosis and inflammation, mitochondrial dysfunction and Ca2+ homeostasis are timely. Here, GHRL is linked to amyotrophic lateral sclerosis.